Fulgent Genetics, Inc.
FLGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $558 | $861 | $896 | $2,958 |
| - Cash | $55 | $97 | $80 | $165 |
| + Debt | $9 | $15 | $21 | $21 |
| Enterprise Value | $513 | $779 | $837 | $2,815 |
| Revenue | $283 | $289 | $619 | $993 |
| % Growth | -2% | -53.3% | -37.6% | – |
| Gross Profit | $107 | $104 | $367 | $777 |
| % Margin | 37.8% | 36.1% | 59.3% | 78.3% |
| EBITDA | -$49 | -$147 | $218 | $687 |
| % Margin | -17.3% | -51% | 35.2% | 69.2% |
| Net Income | -$43 | -$168 | $143 | $507 |
| % Margin | -15.1% | -58% | 23.2% | 51.1% |
| EPS Diluted | -1.41 | -5.63 | 4.63 | 16.26 |
| % Growth | 75% | -221.6% | -71.5% | – |
| Operating Cash Flow | $21 | $27 | $254 | $539 |
| Capital Expenditures | -$40 | -$22 | -$19 | -$24 |
| Free Cash Flow | -$19 | $5 | $235 | $515 |